Blood Clotting and Parkinson Causes and Treatment
The use of lipopolysaccharide (LPS)-binding protein (LBP) to treat Parkinson’s Disease (AD) by reducing hypercoagulation (exaggerated blood clotting) commonly associated with this disease. Brief description The use of lipopolysaccharide (LPS)-binding protein (LBP) to treat Parkinson’s Disease (AD) by reducing hypercoagulation (exaggerated blood clotting) commonly associated with this disease. Unique Characteristics The researchers responsible for the development of this… Read More »